Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $6.85 | Change: $-0.06 | %Change: -0.87%
Volume: 26,514 | Day High/Low: 6.94/6.80 | 52 Week High/Low: 8.33/1.93
View modes: 
0 stars

RE:Wf10 Phase 3 Trial

Good information. Oil prices are down 6% today due to OPEC being unable to staunch the flow of oil. As a result the c$ is taking a pounding and is forecast to hit $0.80 should oil remain below $ more
1 star

Wf10 Phase 3 Trial

Published research can mitigate the cost of clinical trials. There is a substantial published literature base for WF10, including that of Nuvo with respect to earlier trials as a pancreatic more
4 stars

RE:RE:Momentum is slowing...

Beckyl, good point and with that logic, good thing we're not on Nasdaq otherwise it would have tumbled uncontrollably because of Thanksgiving in the U.S. I'm glad your same logic didn't have more
2 stars

RE:RE:Momentum is slowing...

Perspicacity at its best. One never knows ....  rate and reply
3 stars

RE:Momentum is slowing...

dude, if you have not noticed, it's US Thanksgiving week. Volume on the markets this week is a trickle. That's a big part of a momentum loss, combined with a much needed consolidation. A great more
5 stars

Momentum is slowing...

After hitting a mid-day peak of $8.33 it looks more and more like the share price is losing upward momentum and retracing some of the big gains made. Normally this would be panic time but I more
0 stars

RE:RE:WF10 2015 Plans direct from the horses mouth....

Tme will tell .... batting average can only go sideways or up.  rate and reply
1 star

RE:WF10 2015 Plans direct from the horses mouth....

Glad to see that this management team has learned from past experience and appears that they are covering all required documentation and figures the FDA will ask based on past experience. more
1 star

RE:RE:P/E ratio of Nasdaq vs TSX

Management have made it least to me...listen to the last CC...that they are drug developers and do not have the heft to engage in distribution or direct selling. As we have already more
2.5 stars

RE:WF10 2015 Plans direct from the horses mouth....

This clinical trial, consistent with what Lynn said,has a large sample size (186) . This is needed to examine some of the critical outcomes that will be needed to address in a pre-emptive more
5 stars

WF10 2015 Plans direct from the horses mouth....

I posed a question on the Nuvo info line re plans to move forward with Phase III testing with WF10 (assuming positive phase II results), and I received the following response: Thanks for your more
5 stars

RE:RE:RE:P/E ratio of Nasdaq vs TSX

I tend to agree with you ronz that a NASDAQ listing ahead of the WF10 results would be the better way to go. This would give the market the opportunity to bid up the stock price before the more
3 stars

RE:RE:P/E ratio of Nasdaq vs TSX

I would think that having the Nasdaq listing ahead of any WF10 trial results would be absolutely paramount as it would allow for an influx of american investors clammering to buy a piece of this more
3 stars

RE:P/E ratio of Nasdaq vs TSX

From a marketing point of view one would think that a major AND positive announcement (like our WF10 POSITIVE TEST RESULTS !!!! ) just pror to an american listing would surely have a significant more
3.5 stars

P/E ratio of Nasdaq vs TSX

Just curious about the Nasdaq effect on share price, once a listing is secured. Todate, the average p/e for the Nasdaq 100 is 24.7. For the TSX 60 index, the average P/E ratio is 16.7. This is more
1 star

Interesting technology arrangement with Ferndale Pharma

MISSISSAUGA, ON, April 23, 2014 - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced a more
5 stars

RE:RE:RE:Health Care Stocks the place to be

That is , like the pot calling the kettle black. your ' url/source' refers to a number of sites and companies, such as Stem Cell Investing, Orcha Tech and about 5 other companies, all threads more
1.5 stars

RE:RE:Health Care Stocks the place to be

Well, I do have a following on these boards which is as much a congruence of investment tastes and common subscriber ship to several investment sources . Pour moi, my investments are 70  % more
4.5 stars

RE:Health Care Stocks the place to be

But one area of the market is a sure bet to keep growing. It's a sector that has made my readers a lot of money... and will continue to make them money for decades to come. You want more
2.5 stars

Health Care Stocks the place to be

There's a lot of worry in the market right now.   People are worried about Europe going into recession. They're worried about a Chinese slowdown.   But one area of the market is a sure bet to more